id stringlengths 11 11 | tags stringlengths 10 777 | text stringlengths 2 1.5k | dataset_num int64 1 3 | tokens list | ner_tags list |
|---|---|---|---|---|---|
NCT01174121 | 38:60:treatment | Patients who are receiving any other investigational agents | 2 | [
"Patients",
"who",
"are",
"receiving",
"any",
"other",
"investigational",
"agents"
] | [
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT00703105 | 28:53:treatment | Patients who have received prior anti-tumor vaccines are ineligible | 2 | [
"Patients",
"who",
"have",
"received",
"prior",
"anti-tumor",
"vaccines",
"are",
"ineligible"
] | [
0,
0,
0,
0,
1,
1,
1,
0,
0
] |
NCT03089554 | 14:34:chronic_disease,77:93:chronic_disease,107:131:chronic_disease,133:157:chronic_disease,159:177:chronic_disease,182:219:chronic_disease,253:269:treatment | Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with targeted therapy, in the opinion of the treating physician | 2 | [
"Uncontrolled",
"intercurrent",
"illness",
"including",
",",
"but",
"not",
"limited",
"to",
",",
"ongoing",
"or",
"active",
"infection",
",",
"symptomatic",
"congestive",
"heart",
"failure",
",",
"unstable",
"angina",
"pectoris",
",",
"cardiac",
"arrhythmia",
",",... | [
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
2,
2,
2,
0,
2,
2,
2,
0,
2,
2,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03116685 | 1:4:chronic_disease | CKD-EPI formula will be used for adults | 2 | [
"CKD-EPI",
"formula",
"will",
"be",
"used",
"for",
"adults"
] | [
2,
0,
0,
0,
0,
0,
0
] |
NCT02905578 | 15:35:chronic_disease | Uncontrolled, intercurrent illness | 2 | [
"Uncontrolled",
",",
"intercurrent",
"illness"
] | [
0,
0,
2,
2
] |
NCT02640950 | 17:34:chronic_disease, | The patient has attempted suicide within the past 12 months prior to Screening | 2 | [
"The",
"patient",
"has",
"attempted",
"suicide",
"within",
"the",
"past",
"12",
"months",
"prior",
"to",
"Screening"
] | [
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02464878 | 22:41:treatment | Islet donor-directed anti-HLA antibodies detected by Luminex Single Antigen/specificity bead assay including weakly reactive antibodies that would not be detected by a flow cross-match | 2 | [
"Islet",
"donor-directed",
"anti-HLA",
"antibodies",
"detected",
"by",
"Luminex",
"Single",
"Antigen/specificity",
"bead",
"assay",
"including",
"weakly",
"reactive",
"antibodies",
"that",
"would",
"not",
"be",
"detected",
"by",
"a",
"flow",
"cross-match"
] | [
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01705119 | 37:52:treatment | patient was not ambulatory prior to hospitalization | 2 | [
"patient",
"was",
"not",
"ambulatory",
"prior",
"to",
"hospitalization"
] | [
0,
0,
0,
0,
0,
0,
1
] |
NCT02552953 | 14:34:chronic_disease | Uncontrolled intercurrent illness | 2 | [
"Uncontrolled",
"intercurrent",
"illness"
] | [
0,
2,
2
] |
NCT02165007 | 1:7:chronic_disease | stroke | 2 | [
"stroke"
] | [
2
] |
NCT02508467 | 14:38:treatment | has declined treatment with sorafenib | 2 | [
"has",
"declined",
"treatment",
"with",
"sorafenib"
] | [
0,
0,
1,
1,
1
] |
NCT02186418 | ,,124:137:treatment | All participants of reproductive potential must agree to a contraceptive method for a period of no less than one year post gene transfer | 2 | [
"All",
"participants",
"of",
"reproductive",
"potential",
"must",
"agree",
"to",
"a",
"contraceptive",
"method",
"for",
"a",
"period",
"of",
"no",
"less",
"than",
"one",
"year",
"post",
"gene",
"transfer"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT01760005 | 24:74:treatment, | Have been exposed to a monoclonal antibody targeting beta amyloid peptide within the past six months | 2 | [
"Have",
"been",
"exposed",
"to",
"a",
"monoclonal",
"antibody",
"targeting",
"beta",
"amyloid",
"peptide",
"within",
"the",
"past",
"six",
"months"
] | [
0,
0,
0,
0,
0,
1,
1,
1,
1,
1,
1,
0,
0,
0,
0,
0
] |
NCT02509507 | 31:43:cancer | Subjects must have measurable liver tumors and lesions that are suitable for injection | 2 | [
"Subjects",
"must",
"have",
"measurable",
"liver",
"tumors",
"and",
"lesions",
"that",
"are",
"suitable",
"for",
"injection"
] | [
0,
0,
0,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0
] |
NCT03007745 | 10:19:treatment,25:49:treatment,51:68:treatment,73:76:chronic_disease,96:115:treatment | Previous treatment with positive airway pressure, non-nasal surgery for OSA, or current use of supplemental oxygen | 2 | [
"Previous",
"treatment",
"with",
"positive",
"airway",
"pressure",
",",
"non-nasal",
"surgery",
"for",
"OSA",
",",
"or",
"current",
"use",
"of",
"supplemental",
"oxygen"
] | [
0,
1,
0,
1,
1,
1,
0,
1,
1,
0,
2,
0,
0,
0,
0,
0,
1,
1
] |
NCT00719888 | 14:37:chronic_disease,39:48:chronic_disease,66:85:chronic_disease,98:106:chronic_disease,108:127:chronic_disease,129:147:chronic_disease,191:213:chronic_disease,230:259:chronic_disease,293:309:treatment,311:318:chronic_disease,351:360:chronic_disease,364:378:chronic_disease,380:399:chronic_disease,401:424:chronic_disea... | atients with fulminant liver failure, cirrhosis with evidence of portal hypertension or bridging fibrosis, alcoholic hepatitis, esophageal varices, a history of bleeding esophageal varices, hepatic encephalopathy, or correctable hepatic synthetic dysfunction evidenced by prolongation of the prothrombin time, ascites re... | 2 | [
"atients",
"with",
"fulminant",
"liver",
"failure",
",",
"cirrhosis",
"with",
"evidence",
"of",
"portal",
"hypertension",
"or",
"bridging",
"fibrosis",
",",
"alcoholic",
"hepatitis",
",",
"esophageal",
"varices",
",",
"a",
"history",
"of",
"bleeding",
"esophageal"... | [
0,
0,
2,
2,
2,
0,
2,
0,
0,
0,
2,
2,
0,
0,
2,
0,
2,
2,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
2,
0,
0,
0,
0,
0,
2,
0,
2,
2,
0,
2,
2,
0,
2,
2,
2,
0,
0... |
NCT02513797 | 25:31:treatment,33:52:treatment,73:92:treatment,103:115:treatment,117:128:treatment,137:155:treatment | Any contraindication to suture, endovascular device, or other minimally invasive techniques including percutaneous, transseptal, and/or sub-xiphoid access | 2 | [
"Any",
"contraindication",
"to",
"suture",
",",
"endovascular",
"device",
",",
"or",
"other",
"minimally",
"invasive",
"techniques",
"including",
"percutaneous",
",",
"transseptal",
",",
"and/or",
"sub-xiphoid",
"access"
] | [
0,
0,
0,
1,
0,
1,
1,
0,
0,
0,
0,
1,
1,
0,
1,
0,
1,
0,
0,
1,
1
] |
NCT02579967 | 31:55:chronic_disease,71:87:chronic_disease,89:109:chronic_disease,114:124:cancer,137:164:cancer,175:198:cancer | Related donors: No history of opportunistic infections, autoimmunity, hemoglobinopathy, red cell enzymopathy, or malignancy, apart from nonmelanomatous skin cancer or healed cervical cancer in situ | 2 | [
"Related",
"donors",
":",
"No",
"history",
"of",
"opportunistic",
"infections",
",",
"autoimmunity",
",",
"hemoglobinopathy",
",",
"red",
"cell",
"enzymopathy",
",",
"or",
"malignancy",
",",
"apart",
"from",
"nonmelanomatous",
"skin",
"cancer",
"or",
"healed",
"... | [
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
2,
0,
2,
2,
2,
0,
0,
3,
0,
0,
0,
3,
3,
3,
0,
0,
3,
3,
3,
3
] |
NCT03034564 | 13:27:chronic_disease | Significant kidney disease history | 2 | [
"Significant",
"kidney",
"disease",
"history"
] | [
0,
2,
2,
0
] |
NCT02534922 | 27:39:cancer,67:84:cancer,102:139:cancer | Have any other concurrent malignancies, except adequately treated in situ carcinoma of the cervix or basal cell or squamous cell carcinoma of the skin | 2 | [
"Have",
"any",
"other",
"concurrent",
"malignancies",
",",
"except",
"adequately",
"treated",
"in",
"situ",
"carcinoma",
"of",
"the",
"cervix",
"or",
"basal",
"cell",
"or",
"squamous",
"cell",
"carcinoma",
"of",
"the",
"skin"
] | [
0,
0,
0,
0,
3,
0,
0,
0,
0,
3,
3,
3,
0,
0,
0,
0,
3,
3,
3,
3,
3,
3,
0,
0,
0
] |
NCT02369770 | 8:20:chronic_disease | active skin disease with open wounds present below knee of treated limb | 2 | [
"active",
"skin",
"disease",
"with",
"open",
"wounds",
"present",
"below",
"knee",
"of",
"treated",
"limb"
] | [
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01696734 | 12:25:chronic_disease | history of heart failure | 2 | [
"history",
"of",
"heart",
"failure"
] | [
0,
0,
2,
2
] |
NCT01660607 | 1:15:chronic_disease | hepatitis C ab | 2 | [
"hepatitis",
"C",
"ab"
] | [
2,
2,
2
] |
NCT02115685 | 1:27:chronic_disease | bladder or other infection | 2 | [
"bladder",
"or",
"other",
"infection"
] | [
2,
2,
2,
2
] |
NCT02354703 | 114:125:treatment | As of Screen Visit, the subject is sharing a household with a subject randomized to any investigational trial of ondansetron | 2 | [
"As",
"of",
"Screen",
"Visit",
",",
"the",
"subject",
"is",
"sharing",
"a",
"household",
"with",
"a",
"subject",
"randomized",
"to",
"any",
"investigational",
"trial",
"of",
"ondansetron"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02290951 | 1:4:cancer,28:43:treatment,52:78:treatment | NHL patients must have had prior treatment with an anti-CD20 antibody therapy | 2 | [
"NHL",
"patients",
"must",
"have",
"had",
"prior",
"treatment",
"with",
"an",
"anti-CD20",
"antibody",
"therapy"
] | [
3,
0,
0,
0,
0,
1,
1,
0,
0,
1,
1,
1
] |
NCT02567422 | ,,136:147:treatment | Pregnant women are excluded from this study because M6620 (VX-970) as a DNA-damage response (DDR) inhibitor may have the potential for teratogenic or abortifacient effects | 2 | [
"Pregnant",
"women",
"are",
"excluded",
"from",
"this",
"study",
"because",
"M6620",
"(",
"VX-970",
")",
"as",
"a",
"DNA-damage",
"response",
"(",
"DDR",
")",
"inhibitor",
"may",
"have",
"the",
"potential",
"for",
"teratogenic",
"or",
"abortifacient",
"effects... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0
] |
NCT02302235 | 15:29:treatment | non-cytotoxic hormonal agent | 2 | [
"non-cytotoxic",
"hormonal",
"agent"
] | [
0,
1,
1
] |
NCT01087294 | 16:19:chronic_disease,30:41:chronic_disease,72:83:chronic_disease | Donors must be HIV negative, hepatitis B surface antigen negative, and hepatitis C antibody negative | 2 | [
"Donors",
"must",
"be",
"HIV",
"negative",
",",
"hepatitis",
"B",
"surface",
"antigen",
"negative",
",",
"and",
"hepatitis",
"C",
"antibody",
"negative"
] | [
0,
0,
0,
2,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01850355 | 12:39:chronic_disease | History of renal or hepatic impairment | 2 | [
"History",
"of",
"renal",
"or",
"hepatic",
"impairment"
] | [
0,
0,
2,
2,
2,
2
] |
NCT01604512 | 53:61:cancer,96:102:cancer,118:128:cancer,143:153:cancer,173:196:treatment | Pathological or clinical/radiological diagnosis of aneoplasm , either primary (e.g., malignant glioma) or secondary (metastasis from systemic malignancy) with a history of brain radiation therapy | 2 | [
"Pathological",
"or",
"clinical/radiological",
"diagnosis",
"of",
"aneoplasm",
",",
"either",
"primary",
"(",
"e.g.",
",",
"malignant",
"glioma",
")",
"or",
"secondary",
"(",
"metastasis",
"from",
"systemic",
"malignancy",
")",
"with",
"a",
"history",
"of",
"bra... | [
3,
3,
3,
3,
3,
3,
3,
3,
3,
3,
3,
3,
3,
3,
3,
3,
3,
3,
3,
3,
3,
3,
3,
3,
3,
3,
3,
1,
1,
1
] |
NCT02522494 | 14:38:chronic_disease | Diagnosis of type 2 diabetes mellitus | 2 | [
"Diagnosis",
"of",
"type",
"2",
"diabetes",
"mellitus"
] | [
0,
0,
2,
2,
2,
2
] |
NCT02382549 | 1:35:treatment | Allergy desensitization injections | 2 | [
"Allergy",
"desensitization",
"injections"
] | [
1,
1,
1
] |
NCT01972919 | 1:19:treatment,47:53:cancer,86:103:treatment | Prior radiotherapy to the region of the study cancer that would result in overlap of radiation therapy fields | 2 | [
"Prior",
"radiotherapy",
"to",
"the",
"region",
"of",
"the",
"study",
"cancer",
"that",
"would",
"result",
"in",
"overlap",
"of",
"radiation",
"therapy",
"fields"
] | [
1,
1,
0,
0,
0,
0,
0,
0,
3,
0,
0,
0,
0,
0,
0,
1,
1,
0
] |
NCT02519283 | 18:20:chronic_disease | Prior history of HF | 2 | [
"Prior",
"history",
"of",
"HF"
] | [
0,
0,
0,
2
] |
NCT01591356 | ,,,,,,,,319:343:treatment | Female subject is either post-menopausal or surgically sterilized or willing to use an acceptable method of birth control (i.e., a hormonal contraceptive, intrauterine device, diaphragm with spermicide, condom with spermicide, or abstinence) for the duration of the study and for at least 3 months after completion of Ep... | 2 | [
"Female",
"subject",
"is",
"either",
"post-menopausal",
"or",
"surgically",
"sterilized",
"or",
"willing",
"to",
"use",
"an",
"acceptable",
"method",
"of",
"birth",
"control",
"(",
"i.e.",
",",
"a",
"hormonal",
"contraceptive",
",",
"intrauterine",
"device",
","... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1
] |
NCT02138214 | 16:34:cancer | No evidence of distant metastases | 2 | [
"No",
"evidence",
"of",
"distant",
"metastases"
] | [
0,
0,
0,
3,
3
] |
NCT02140255 | 49:62:chronic_disease | Any clinically significant diseases (other than HIV infection) or clinically significant findings during review of medical history or physical examination prior to entry that, in the investigator's opinion, would interfere with study participation or interpretation | 2 | [
"Any",
"clinically",
"significant",
"diseases",
"(",
"other",
"than",
"HIV",
"infection",
")",
"or",
"clinically",
"significant",
"findings",
"during",
"review",
"of",
"medical",
"history",
"or",
"physical",
"examination",
"prior",
"to",
"entry",
"that",
",",
"i... | [
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03027388 | 31:41:treatment | Patients unwilling to undergo craniotomy | 2 | [
"Patients",
"unwilling",
"to",
"undergo",
"craniotomy"
] | [
0,
0,
0,
0,
1
] |
NCT03034863 | 44:61:chronic_disease | evidence of current (within the past week) suicidal ideation | 2 | [
"evidence",
"of",
"current",
"(",
"within",
"the",
"past",
"week",
")",
"suicidal",
"ideation"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2
] |
NCT03008070 | 78:117:allergy_name | Have a known hypersensitivity to any of the ingredients or excipients of the Investigational medicinal product (IMP) | 2 | [
"Have",
"a",
"known",
"hypersensitivity",
"to",
"any",
"of",
"the",
"ingredients",
"or",
"excipients",
"of",
"the",
"Investigational",
"medicinal",
"product",
"(",
"IMP",
")"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
4,
4,
4,
4,
0,
0
] |
NCT02912572 | 45:53:allergy_name | History of allergic reactions attributed to avelumab or any component in its formulations, or compounds of similar chemical or biologic composition to avelumab | 2 | [
"History",
"of",
"allergic",
"reactions",
"attributed",
"to",
"avelumab",
"or",
"any",
"component",
"in",
"its",
"formulations",
",",
"or",
"compounds",
"of",
"similar",
"chemical",
"or",
"biologic",
"composition",
"to",
"avelumab"
] | [
0,
0,
0,
0,
0,
0,
4,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02570672 | 1:13:chronic_disease,23:35:treatment,,,137:145:chronic_disease, | Pre-diabetic based on oral glucose tolerance test with 2 hour values of 140 - 199 mg/dL after an oral glucose load, and no diagnosis of diabetes in the past 12 months | 2 | [
"Pre-diabetic",
"based",
"on",
"oral",
"glucose",
"tolerance",
"test",
"with",
"2",
"hour",
"values",
"of",
"140",
"-",
"199",
"mg/dL",
"after",
"an",
"oral",
"glucose",
"load",
",",
"and",
"no",
"diagnosis",
"of",
"diabetes",
"in",
"the",
"past",
"12",
... | [
2,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
0,
0,
0
] |
NCT02600897 | 16:45:treatment,50:75:treatment,88:100:treatment,102:113:treatment,118:129:treatment,,148:168:treatment,,186:189:treatment,193:216:treatment,,236:248:treatment,249:261:treatment,262:277:treatment,278:309:treatment, | Current use of systemic immunosuppressant(s), or prior anti-cancer therapy to include: lenalidomide, fludarabine, or alemtuzumab within 12 months; radioimmunoconjugate within 12 weeks; mAb or antibody-drug conjugate within 4 weeks; or radiotherapy/chemotherapy/hormone therapy/targeted small-molecule therapy within 2 we... | 2 | [
"Current",
"use",
"of",
"systemic",
"immunosuppressant",
"(",
"s",
")",
",",
"or",
"prior",
"anti-cancer",
"therapy",
"to",
"include",
":",
"lenalidomide",
",",
"fludarabine",
",",
"or",
"alemtuzumab",
"within",
"12",
"months",
";",
"radioimmunoconjugate",
"with... | [
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
1,
0,
1,
0,
0,
1,
0,
0,
0,
0,
1,
0,
0,
0,
0,
1,
0,
1,
1,
0,
0,
0,
0,
0,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02474667 | 29:53:treatment | Patients may participate in another concurrent study only if that study is a non-interventional, observational investigation | 2 | [
"Patients",
"may",
"participate",
"in",
"another",
"concurrent",
"study",
"only",
"if",
"that",
"study",
"is",
"a",
"non-interventional",
",",
"observational",
"investigation"
] | [
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02414178 | 22:25:treatment,27:33:treatment,37:39:treatment,46:72:treatment | Contraindications to PET, PET-CT or MR (e.g. electronic medical devices, inability to lie still for long periods) that make it unsafe for the individual to participate | 2 | [
"Contraindications",
"to",
"PET",
",",
"PET-CT",
"or",
"MR",
"(",
"e.g",
".",
"electronic",
"medical",
"devices",
",",
"inability",
"to",
"lie",
"still",
"for",
"long",
"periods",
")",
"that",
"make",
"it",
"unsafe",
"for",
"the",
"individual",
"to",
"part... | [
0,
0,
1,
0,
1,
0,
1,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02245841 | 1:14:chronic_disease | renal disease | 2 | [
"renal",
"disease"
] | [
2,
2
] |
NCT02033616 | 82:107:cancer | Successful establishment of an autologous epithelial ovarian, fallopian tube, or primary peritoneal cancer cell line by AIVITA Biomedical, Inc | 2 | [
"Successful",
"establishment",
"of",
"an",
"autologous",
"epithelial",
"ovarian",
",",
"fallopian",
"tube",
",",
"or",
"primary",
"peritoneal",
"cancer",
"cell",
"line",
"by",
"AIVITA",
"Biomedical",
",",
"Inc"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0
] |
NCT02204098 | ,28:31:treatment, | no menses for <1 year with FSH and estradiol levels in postmenopausal range, according to institutional standards | 2 | [
"no",
"menses",
"for",
"<",
"1",
"year",
"with",
"FSH",
"and",
"estradiol",
"levels",
"in",
"postmenopausal",
"range",
",",
"according",
"to",
"institutional",
"standards"
] | [
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01903330 | 19:31:treatment,35:44:treatment,,101:109:chronic_disease | Resolution of all chemotherapy or radiation-related toxicities ≤ CTCAE Grade 1 severity, except for alopecia and hematologic toxicity | 2 | [
"Resolution",
"of",
"all",
"chemotherapy",
"or",
"radiation-related",
"toxicities",
"≤",
"CTCAE",
"Grade",
"1",
"severity",
",",
"except",
"for",
"alopecia",
"and",
"hematologic",
"toxicity"
] | [
0,
0,
0,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
0
] |
NCT02131389 | 5:22:chronic_disease | Has hip joint disease related to one or more | 2 | [
"Has",
"hip",
"joint",
"disease",
"related",
"to",
"one",
"or",
"more"
] | [
0,
2,
2,
2,
0,
0,
0,
0,
0
] |
NCT02881320 | 1:121:treatment, | Stable antiretroviral regimen of 2 nucleoside reverse transcriptase inhibitors (NRTIs) in combination with a third agent for a minimum of 6 months prior to the screening visit | 2 | [
"Stable",
"antiretroviral",
"regimen",
"of",
"2",
"nucleoside",
"reverse",
"transcriptase",
"inhibitors",
"(",
"NRTIs",
")",
"in",
"combination",
"with",
"a",
"third",
"agent",
"for",
"a",
"minimum",
"of",
"6",
"months",
"prior",
"to",
"the",
"screening",
"vis... | [
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02493530 | 1:23:treatment | bone marrow transplant | 2 | [
"bone",
"marrow",
"transplant"
] | [
1,
1,
1
] |
NCT00719888 | ,,42:73:treatment | blasts must be < 10% by a representative bone marrow aspirate morphology | 2 | [
"blasts",
"must",
"be",
"<",
"10",
"%",
"by",
"a",
"representative",
"bone",
"marrow",
"aspirate",
"morphology"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1
] |
NCT02127398 | 1:19:chronic_disease | Short gut syndrome requiring total parenteral nutrition | 2 | [
"Short",
"gut",
"syndrome",
"requiring",
"total",
"parenteral",
"nutrition"
] | [
2,
2,
2,
0,
0,
0,
0
] |
NCT03012815 | 40:50:treatment | Patients receiving therapeutic dose of gabapentin (rather than continuation of home dose) prior to enrollment | 2 | [
"Patients",
"receiving",
"therapeutic",
"dose",
"of",
"gabapentin",
"(",
"rather",
"than",
"continuation",
"of",
"home",
"dose",
")",
"prior",
"to",
"enrollment"
] | [
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02501733 | 15:26:treatment | Patients with knee fusion to the affected joint | 2 | [
"Patients",
"with",
"knee",
"fusion",
"to",
"the",
"affected",
"joint"
] | [
0,
0,
1,
1,
0,
0,
0,
0
] |
NCT01817751 | 61:79:treatment,102:115:treatment,119:128:treatment | efforts may be made by the treating physician to change the antiepileptic drug from another agent to valproic acid or non-EIAED prior to excluding the patient from study | 2 | [
"efforts",
"may",
"be",
"made",
"by",
"the",
"treating",
"physician",
"to",
"change",
"the",
"antiepileptic",
"drug",
"from",
"another",
"agent",
"to",
"valproic",
"acid",
"or",
"non-EIAED",
"prior",
"to",
"excluding",
"the",
"patient",
"from",
"study"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
1,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT02581215 | 36:50:cancer,70:91:cancer,93:111:cancer,113:120:cancer,124:132:cancer | Subjects with histology other than adenocarcinoma; Examples include: neuroendocrine tumors, acinar cell cancer, sarcoma or lymphoma of the pancreas | 2 | [
"Subjects",
"with",
"histology",
"other",
"than",
"adenocarcinoma",
";",
"Examples",
"include",
":",
"neuroendocrine",
"tumors",
",",
"acinar",
"cell",
"cancer",
",",
"sarcoma",
"or",
"lymphoma",
"of",
"the",
"pancreas"
] | [
0,
0,
0,
0,
0,
3,
0,
0,
0,
0,
3,
3,
0,
3,
3,
3,
0,
3,
0,
3,
0,
0,
0
] |
NCT02433977 | 1:7:chronic_disease,, | Asthma diagnosed at age 9 or later | 2 | [
"Asthma",
"diagnosed",
"at",
"age",
"9",
"or",
"later"
] | [
2,
0,
0,
0,
0,
0,
0
] |
NCT03093272 | 32:39:chronic_disease | Medications known to lower the seizure threshold must be discontinued | 2 | [
"Medications",
"known",
"to",
"lower",
"the",
"seizure",
"threshold",
"must",
"be",
"discontinued"
] | [
0,
0,
0,
0,
0,
2,
0,
0,
0,
0
] |
NCT01505062 | 25:34:chronic_disease, | Intercurrent illness or infection 28 days prior to SAR421869 administration | 2 | [
"Intercurrent",
"illness",
"or",
"infection",
"28",
"days",
"prior",
"to",
"SAR421869",
"administration"
] | [
0,
0,
0,
2,
0,
0,
0,
0,
0,
0
] |
NCT03069469 | 14:28:cancer | Known active CNS metastases | 2 | [
"Known",
"active",
"CNS",
"metastases"
] | [
0,
0,
3,
3
] |
NCT02393157 | 1:9:treatment | Steroids | 2 | [
"Steroids"
] | [
1
] |
NCT01903330 | 1:17:chronic_disease,28:37:treatment,45:70:chronic_disease,79:107:chronic_disease,116:121:chronic_disease,134:168:treatment | Active infection requiring treatment, known immunosuppressive disease, active systemic autoimmune diseases such as lupus, receipt of systemic immunosuppressive therapy | 2 | [
"Active",
"infection",
"requiring",
"treatment",
",",
"known",
"immunosuppressive",
"disease",
",",
"active",
"systemic",
"autoimmune",
"diseases",
"such",
"as",
"lupus",
",",
"receipt",
"of",
"systemic",
"immunosuppressive",
"therapy"
] | [
2,
2,
0,
1,
0,
0,
2,
2,
0,
0,
1,
1,
1,
0,
0,
2,
0,
0,
0,
0,
0,
0
] |
NCT02465268 | 7:26:cancer, | Prior invasive malignancy unless disease free for ≥ 3 years | 2 | [
"Prior",
"invasive",
"malignancy",
"unless",
"disease",
"free",
"for",
"≥",
"3",
"years"
] | [
0,
3,
3,
0,
0,
0,
0,
0,
0,
0
] |
NCT01996865 | 17:32:treatment,,62:71:treatment,,132:142:treatment | Subjects taking corticosteroids during the last 1 week prior treatment, unless administered at a dose equivalent to < 20 mg/day of prednisone | 2 | [
"Subjects",
"taking",
"corticosteroids",
"during",
"the",
"last",
"1",
"week",
"prior",
"treatment",
",",
"unless",
"administered",
"at",
"a",
"dose",
"equivalent",
"to",
"<",
"20",
"mg/day",
"of",
"prednisone"
] | [
0,
0,
1,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02019641 | 124:133:chronic_disease,135:149:chronic_disease,151:163:chronic_disease,165:180:chronic_disease | Other medical conditions that would impair aerobic capacity or the ability to engage in physical activity, including other pulmonary, cardiovascular, neurological, musculoskeletal or metabolic conditions | 2 | [
"Other",
"medical",
"conditions",
"that",
"would",
"impair",
"aerobic",
"capacity",
"or",
"the",
"ability",
"to",
"engage",
"in",
"physical",
"activity",
",",
"including",
"other",
"pulmonary",
",",
"cardiovascular",
",",
"neurological",
",",
"musculoskeletal",
"o... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
2,
0,
2,
0,
2,
0,
0,
0
] |
NCT02519322 | 49:52:treatment | this interval depends on the type and dosage of HRT | 2 | [
"this",
"interval",
"depends",
"on",
"the",
"type",
"and",
"dosage",
"of",
"HRT"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02013778 | 8:21:chronic_disease, | Active GI hemorrhage within 2 weeks of study enrollment | 2 | [
"Active",
"GI",
"hemorrhage",
"within",
"2",
"weeks",
"of",
"study",
"enrollment"
] | [
0,
2,
2,
0,
0,
0,
0,
0,
0
] |
NCT00871260 | 1:19:treatment,33:36:treatment,38:47:treatment,49:62:treatment | Contra-indications to MRI (i.e. ICD, pacemaker, aneurysm clip, etc) | 2 | [
"Contra-indications",
"to",
"MRI",
"(",
"i.e",
".",
"ICD",
",",
"pacemaker",
",",
"aneurysm",
"clip",
",",
"etc",
")"
] | [
1,
0,
0,
0,
0,
0,
1,
0,
1,
0,
1,
1,
0,
0,
0
] |
NCT02253316 | ,37:44:treatment,56:72:treatment,77:93:cancer,,,142:157:treatment | Received at least two cycles of any regimen as initial systemic therapy for multiple myeloma and are within 2-16 months of the first dose of initial therapy | 2 | [
"Received",
"at",
"least",
"two",
"cycles",
"of",
"any",
"regimen",
"as",
"initial",
"systemic",
"therapy",
"for",
"multiple",
"myeloma",
"and",
"are",
"within",
"2-16",
"months",
"of",
"the",
"first",
"dose",
"of",
"initial",
"therapy"
] | [
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
1,
1,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01757418 | 11:17:chronic_disease,38:58:treatment,62:88:treatment | Increased stroke risk as assessed by transcranial Doppler or magnetic resonance imaging (all subjects undergo testing) | 2 | [
"Increased",
"stroke",
"risk",
"as",
"assessed",
"by",
"transcranial",
"Doppler",
"or",
"magnetic",
"resonance",
"imaging",
"(",
"all",
"subjects",
"undergo",
"testing",
")"
] | [
0,
2,
0,
0,
0,
0,
1,
1,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0
] |
NCT01011777 | 1:30:chronic_disease | Grade V vesicoureteral reflux (Grade IV findings plus loss of the papillary impression and ureteral tortuosity) | 2 | [
"Grade",
"V",
"vesicoureteral",
"reflux",
"(",
"Grade",
"IV",
"findings",
"plus",
"loss",
"of",
"the",
"papillary",
"impression",
"and",
"ureteral",
"tortuosity",
")"
] | [
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02466971 | 32:58:cancer | Patient has another concurrent active invasive malignancy | 2 | [
"Patient",
"has",
"another",
"concurrent",
"active",
"invasive",
"malignancy"
] | [
0,
0,
0,
0,
3,
3,
3
] |
NCT02582775 | 16:19:chronic_disease | beta 3 laminin JEB mutants | 2 | [
"beta",
"3",
"laminin",
"JEB",
"mutants"
] | [
0,
0,
0,
2,
0
] |
NCT02929069 | 9:39:chronic_disease | Current suicidal or homicidal ideation | 2 | [
"Current",
"suicidal",
"or",
"homicidal",
"ideation"
] | [
0,
2,
2,
2,
2
] |
NCT03179397 | 38:54:chronic_disease,61:81:chronic_disease,91:108:chronic_disease,, | Subjects with diagnosed degenerative visual disorders (e.g. macular degeneration or other retinal disorders) that are predicted to cause future acuity losses to a level worse than 0.2 LogMAR (20/32) | 2 | [
"Subjects",
"with",
"diagnosed",
"degenerative",
"visual",
"disorders",
"(",
"e.g",
".",
"macular",
"degeneration",
"or",
"other",
"retinal",
"disorders",
")",
"that",
"are",
"predicted",
"to",
"cause",
"future",
"acuity",
"losses",
"to",
"a",
"level",
"worse",
... | [
0,
0,
0,
0,
2,
2,
0,
0,
0,
2,
2,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02535312 | 12:24:treatment,28:40:treatment,132:146:chronic_disease,377:388:treatment | documented hysterectomy or oophorectomy must be confirmed with medical records of the actual procedure or confirmed by ultrasound; tubal ligation must be confirmed with medical records of the actual procedure otherwise the patient must be willing to use 2 adequate barrier methods throughout the study, starting with the... | 2 | [
"documented",
"hysterectomy",
"or",
"oophorectomy",
"must",
"be",
"confirmed",
"with",
"medical",
"records",
"of",
"the",
"actual",
"procedure",
"or",
"confirmed",
"by",
"ultrasound",
";",
"tubal",
"ligation",
"must",
"be",
"confirmed",
"with",
"medical",
"records... | [
0,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01684397 | 1:21:cancer,25:48:cancer,89:98:treatment | basal cell carcinoma or squamous cell carcinoma, of skin which were completely cured by resection | 2 | [
"basal",
"cell",
"carcinoma",
"or",
"squamous",
"cell",
"carcinoma",
",",
"of",
"skin",
"which",
"were",
"completely",
"cured",
"by",
"resection"
] | [
3,
3,
3,
0,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02734771 | 1:19:cancer | Composite lymphoma containing both indolent and large cell features will be included | 2 | [
"Composite",
"lymphoma",
"containing",
"both",
"indolent",
"and",
"large",
"cell",
"features",
"will",
"be",
"included"
] | [
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02169037 | 24:38:allergy_name | untreatable allergy to contrast media | 2 | [
"untreatable",
"allergy",
"to",
"contrast",
"media"
] | [
0,
0,
0,
4,
4
] |
NCT03086369 | 40:68:cancer | Have received first line treatment for metastatic pancreatic cancer | 2 | [
"Have",
"received",
"first",
"line",
"treatment",
"for",
"metastatic",
"pancreatic",
"cancer"
] | [
0,
0,
0,
0,
0,
0,
3,
3,
3
] |
NCT01903330 | ,,,,,92:106:chronic_disease | blood pressure of > 150 mmHg systolic and > 100 mmHg diastolic, or history of hypertensive encephalopathy | 2 | [
"blood",
"pressure",
"of",
">",
"150",
"mmHg",
"systolic",
"and",
">",
"100",
"mmHg",
"diastolic",
",",
"or",
"history",
"of",
"hypertensive",
"encephalopathy"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2
] |
NCT02746458 | 14:32:chronic_disease | Diagnosis of sickle cell anemia | 2 | [
"Diagnosis",
"of",
"sickle",
"cell",
"anemia"
] | [
0,
0,
2,
2,
2
] |
NCT01865162 | 44:72:treatment,74:83:treatment,88:113:treatment | Documented recurrence or progression after surgical resection/debulking, radiation and temozolamide chemotherapy | 2 | [
"Documented",
"recurrence",
"or",
"progression",
"after",
"surgical",
"resection/debulking",
",",
"radiation",
"and",
"temozolamide",
"chemotherapy"
] | [
0,
0,
0,
0,
0,
1,
1,
0,
1,
0,
1,
1
] |
NCT02939755 | 58:64:cancer | a spouse or cohabitating intimate partner of an advanced cancer patient being evaluated at the UPMC's LCC | 2 | [
"a",
"spouse",
"or",
"cohabitating",
"intimate",
"partner",
"of",
"an",
"advanced",
"cancer",
"patient",
"being",
"evaluated",
"at",
"the",
"UPMC",
"'s",
"LCC"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02502708 | 15:33:cancer | Patients with metastatic disease are eligible for enrollment | 2 | [
"Patients",
"with",
"metastatic",
"disease",
"are",
"eligible",
"for",
"enrollment"
] | [
0,
0,
3,
3,
0,
0,
0,
0
] |
NCT01356290 | 27:59:allergy_name | Known hypersensitivity to any of the drugs in the protocol | 2 | [
"Known",
"hypersensitivity",
"to",
"any",
"of",
"the",
"drugs",
"in",
"the",
"protocol"
] | [
0,
0,
0,
4,
4,
4,
4,
4,
4,
4
] |
NCT01581580 | 18:31:chronic_disease | The diagnosis of idiopathic PD will be based on the UK Brain Bank Criteria | 2 | [
"The",
"diagnosis",
"of",
"idiopathic",
"PD",
"will",
"be",
"based",
"on",
"the",
"UK",
"Brain",
"Bank",
"Criteria"
] | [
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02013336 | 43:56:cancer,58:74:cancer,76:89:cancer,94:106:cancer | Histologically or cytologically-confirmed Ewing sarcoma, rhabdomyosarcoma, neuroblastoma, or osteosarcoma | 2 | [
"Histologically",
"or",
"cytologically-confirmed",
"Ewing",
"sarcoma",
",",
"rhabdomyosarcoma",
",",
"neuroblastoma",
",",
"or",
"osteosarcoma"
] | [
0,
0,
0,
3,
3,
0,
3,
0,
3,
0,
0,
3
] |
NCT02724930 | 1:14:chronic_disease | schizophrenia | 2 | [
"schizophrenia"
] | [
2
] |
NCT01895777 | 1:13:treatment,, | Transfusions during the screening period are allowed, provided that a satisfactory hemoglobin or platelet level is attained prior to visit 2 | 2 | [
"Transfusions",
"during",
"the",
"screening",
"period",
"are",
"allowed",
",",
"provided",
"that",
"a",
"satisfactory",
"hemoglobin",
"or",
"platelet",
"level",
"is",
"attained",
"prior",
"to",
"visit",
"2"
] | [
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01581580 | 19:42:treatment | good benefit from dopaminergic medication but associated with insufficient duration of action or unacceptable side-effects | 2 | [
"good",
"benefit",
"from",
"dopaminergic",
"medication",
"but",
"associated",
"with",
"insufficient",
"duration",
"of",
"action",
"or",
"unacceptable",
"side-effects"
] | [
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02226341 | 1:23:chronic_disease | Active lupus nephritis | 2 | [
"Active",
"lupus",
"nephritis"
] | [
2,
2,
2
] |
NCT02141074 | 36:59:treatment, | Previously untreated or exposed to FIX containing products less than or equal to 3 exposure days (5 previous exposures to blood components is acceptable) | 2 | [
"Previously",
"untreated",
"or",
"exposed",
"to",
"FIX",
"containing",
"products",
"less",
"than",
"or",
"equal",
"to",
"3",
"exposure",
"days",
"(",
"5",
"previous",
"exposures",
"to",
"blood",
"components",
"is",
"acceptable",
")"
] | [
0,
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02329327 | 1:23:chronic_disease,25:46:chronic_disease,48:92:chronic_disease,122:147:chronic_disease,149:173:chronic_disease,200:227:chronic_disease, | venous thromboembolism, myocardial infarction, disseminated intravascular coagulation (DIC), cerebral vascular accident, transient ischemic attack, unstable angina pectoris hospitalization or severe peripheral vascular disease within 2 weeks prior to screening | 2 | [
"venous",
"thromboembolism",
",",
"myocardial",
"infarction",
",",
"disseminated",
"intravascular",
"coagulation",
"(",
"DIC",
")",
",",
"cerebral",
"vascular",
"accident",
",",
"transient",
"ischemic",
"attack",
",",
"unstable",
"angina",
"pectoris",
"hospitalization... | [
2,
2,
0,
2,
2,
0,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2,
0,
2,
2,
2,
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0
] |
NCT02271919 | ,28:50:chronic_disease,52:74:chronic_disease,76:82:chronic_disease,84:90:chronic_disease,92:104:chronic_disease | History (last 3 months) of abnormal heart rhythms, cardiovascular disease (stroke, angina, heart attack) may result in ineligibility; these conditions will be evaluated on a case by case basis by the study physician | 2 | [
"History",
"(",
"last",
"3",
"months",
")",
"of",
"abnormal",
"heart",
"rhythms",
",",
"cardiovascular",
"disease",
"(",
"stroke",
",",
"angina",
",",
"heart",
"attack",
")",
"may",
"result",
"in",
"ineligibility",
";",
"these",
"conditions",
"will",
"be",
... | [
0,
0,
0,
0,
0,
0,
0,
2,
2,
2,
0,
2,
2,
0,
2,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01453088 | ,,26:41:treatment | Age ≥60 years at time of transplantation | 2 | [
"Age",
"≥60",
"years",
"at",
"time",
"of",
"transplantation"
] | [
0,
0,
0,
0,
0,
0,
1
] |
NCT02114229 | ,,,82:106:chronic_disease | Performance status defined by Karnofsky or Lansky > 60 (except for patients with posterior fossa syndrome) | 2 | [
"Performance",
"status",
"defined",
"by",
"Karnofsky",
"or",
"Lansky",
">",
"60",
"(",
"except",
"for",
"patients",
"with",
"posterior",
"fossa",
"syndrome",
")"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2,
0
] |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.